Jilin Aodong Pharmaceutical Group Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | The predecessor of Jilin Aodong Pharmaceutical Group Co., Ltd. was the state-owned Yanbian Dunhua Deer Farm established in 1957. Aodong Pharmaceutical Factory was established in 1981, and was restructured into Jilin Aodong Pharmaceutical Group Co., Ltd. with the approval of the Provincial Commission for Restructuring in March 1993. It was listed on the Shenzhen Stock Exchange on October 28, 1996. The company holds a total of 6 professional pharmaceutical subsidiaries engaged in modern Chinese medicine, biochemical medicine, and phytochemical medicine, 1 pharmaceutical research and development subsidiary, 5 pharmaceutical sales subsidiaries, 6 pharmaceutical supporting subsidiaries, 2 high-end health product companies, 1 highway construction toll company, and 1 Aodong International (Hong Kong) Industrial Co., Ltd. It has planting and breeding bases, and has established an industrial chain management model of "company+standardization base+licensed farmers", Gradually developing into a holding group listed company based on the pharmaceutical industry and rapidly developing through a dual wheel drive model of "industry+finance". At present, the company is the largest shareholder of Guangfa Securities Co., Ltd. (securities abbreviation: Guangfa Securities, securities code: 000776.SZ, 1776. HK), and also invests in Liaoning Chengda Co., Ltd. (securities abbreviation: Liaoning Chengda, securities code: 600739. SH), Shanghai First Pharmaceutical Co., Ltd. (securities abbreviation: First Pharmaceutical, securities code: 600833. SH), Nanjing Pharmaceutical Co., Ltd. (securities abbreviation: Nanjing Pharmaceutical, securities code: 600713. SH) Jilin Boya Special Medical Nutrition Technology Co., Ltd. The company has successively won the National Torch Plan Key High tech Enterprise, National High tech Enterprise, National Innovative Enterprise, National Intellectual Property Advantage Enterprise, National Model Enterprise with Harmonious Labor Relations, National May Day Labor Award, National exemplary organization for Open and Democratic Management of Factory Affairs, National Non public Enterprise "Double Top 100" Party Organization, the 16th and 21st National Enterprise Management Modernization Innovation Achievement First Prize For many consecutive years, it has been rated as an A-level taxpayer, an AAA level "contract abiding and trustworthy" unit, and many other honors. For more than ten consecutive years, it has been ranked among the top 100 pharmaceutical industry in China and the "China 500 Most Valuable Brands", with asset quality ranking among the top in the industry. |
| Headquarter | Yanbian Korean Autonomous Prefecture |
| Establish Date | 3/20/1993 |
| Listed Code | 000623.SZ |
| Listed Date | 10/28/1996 |
| Chairman | Li Xiulin. |
| CEO | Guo Shuqin. |
| Website | www.jlaod.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
